Clinical Trial to Evaluate the Safety and Efficacy of JTM201 to Treat Moderate or Severe Glabellar Lines
Phase 2
Not yet recruiting
- Conditions
- Glabellar Lines
- Interventions
- Biological: JTM201Biological: Placebo
- First Posted Date
- 2024-02-07
- Last Posted Date
- 2024-02-08
- Lead Sponsor
- Jetema USA Inc.
- Target Recruit Count
- 480
- Registration Number
- NCT06246552
© Copyright 2025. All Rights Reserved by MedPath